New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia

Cellular and Molecular Life Sciences

Volumn 57, Issue 6, 2000, Pages 932-942

  Werner, H ^a   Le Roith, D ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer; IGF I receptor; Insulin like growth factors; Receptor signaling

Indexed keywords

FIBROBLAST GROWTH FACTOR; GENE PRODUCT; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; SUPPRESSOR FACTOR; TYROSINE KINASE RECEPTOR;

BREAST CANCER; CANCER; CELL PROLIFERATION; FUNCTIONAL ASSESSMENT; GROWTH REGULATION; HUMAN; MUTATION; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW;

EID: 0033911567     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000735     Document Type: Review

References (82)

1. 1 Rosenfeld R. G. and Roberts C. T. Jr (1999) The IGF System: Molecular Biology, Physiology and Clinical Applications. Humana Press. Totowa, NJ
2. 2 Roberts C. T. Jr, Brown A. L., Graham D. E., Seelig S., Berry S., Gabbay K. H. et al. (1986) J. Biol. Chem. 261: 10025-10028
3. 3 Adamo M. L., Ben-Hur H., Roberts C. T. Jr and LeRoith D. (1991) Regulation of start site usage in the two leader exons of the rat insulin-like growth factor I gene by development, fasting and diabetes. Mol. Endocrinol. 5: 1677-1686
4. 4 Salmon W. D. and Daughaday W. H. (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J. Lab. Clin. Med. 49: 825-836
5. 5 D'Ercole A. J., Applewhite G. T. and Underwood L. E. (1980) Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev. Biol. 75: 315-322
6. 6 Yakar S., Liu J. L., Stannard B., Butler A., Accili D., Sauer B. et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96: 7324-7329
7. 7 Morrione A., Valentinis B., Xu S., Yumet G., Louvi A., Efstratiadis A. et al. (1997) Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. USA 94: 3777-3782
8. 8 Nissley S. P. (1999) Type 2 IGE receptor-mediated events. In: The IGF System: Molecular Biology, Physiology and Clinical Applications, pp. 165-197, Rosenfeld R. G. and Roberts C. T. Jr (eds), Humana Press, Totowa, NJ
9. 9 Kiess W. (1999) Molecular biology of the IGE-II mannose-6-phosphate receptor. In: The IGF System: Molecular Biology, Physiology and Clinical Applications, pp. 89-109, Rosenfeld R. G. and Roberts C. T. Jr (eds). Humana Press, Totowa, NJ
10. 10 Siddle K. and Soos M. A. (1999) Alternative IGF-relaled receptors. In: The IGF System: Molecular Biology, Physiology and Clinical Applications, pp. 199-225, Rosenfeld R. G. and Roberts C. T. Jr (eds), Humana Press, Totowa, NJ
11. 11 LeRoith D., Werner H., Beitner-Johnson D. and Roberts C. T. Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev. 16: 143-163
12. 12 Shier P. and Watt V. M. (1989) Primary structure of a putative receptor for a ligand of the insulin family. J. Biol. Chem. 264: 14605-14608
13. 13 Zhang B. and Roth R. A. (1992) The insulin receptor-related receptor. Tissue expression, ligand binding specificity and signaling capabilities. J. Biol. Chem. 267: 18320-18328
14. 14 Soos M. A., Field C. E. and Siddle K. (1993) Purified hybrid insulin insulin-like growth factor-1 receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290: 419-425
15. 15 Kasuya J., Paz B., Maddux B. A., Goldfine I. D., Hefta S. A. and Fujita-Yamaguchi Y. (1993) Characterization of human placental insulin-like growth factor-I insulin hybrid receptors by protein microsequencing and purification. Biochemistry 32: 13531-13536
16. 16 Frattali A. L. and Pessin J. E. (1993) Relationship between α subunit ligand occupancy and β subunit autophosphorylation in insulin insulin-like growth factor-I hybrid receptors. J. Biol. Chem. 268: 7393-7400
17. 17 Bailyes E. M., Nave B. T., Soos M. A., Orr S. R., Hayward A. C. and Siddle K. (1997) Insulin receptor IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J. 327: 209-215
18. 18 Baxter R. C., Binoux M. A., Clemmons D. R., Conover C. A., Drop S. L. S., Holly J. M. P. et al. (1998) Recomcndations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology 139: 4036
19. 19 Hwa V., Oh Y., Burren C. P., Choi W.-K., Graham D. L., Ingermann A. et al. (1999) The IGF binding protein superfamily. In: The IGF System: Molecular Biology, Physiology and Clinical Applications, pp. 315-327, Rosenfeld R. G. and Roberts C. T. Jr (eds), Humana Press, Totowa, NJ
20. 20 Ullrich A., Gray A., Tam A. W., Yang-Feng T., Tsubowka M., Collins C. et al. (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests determinants that define functional specificity. EMBO J. 5: 2503-2512
21. 21 Myers M. G. Jr, Backer J. M., Sun X.-J., Shoelson S. E., Hu P., Schlessinger J. et al. (1992) IRS-1 activates the phosphatidylinositor 3′-kinase by associating with the src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA 89: 10350-10354
22. 22 Myers M. G. Jr, Sun X.-J., Cheatham B., Jachna B. R., Glasheen E. M., Backer J. M. et al. (1993) IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132: 1421-1430
23. 23 White M. F. and Kahn C. R. (1994) The insulin signaling system. J. Biol. Chem. 269: 1-4
24. 24 Beitner-Johnson D. and LeRoith D. (1995) Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J. Biol. Chem. 270: 5187-5190
25. 25 Beitner-Johnson D., Blakesley V. A., Shen-Orr Z., Jimenez M., Stannard B., Wang L.-M. et al. (1996) The proto-oncogene product c-Crk associates with insulin receptor substrate-I and 4PS: modulation by insulin growth factor-I (IGF-I) and enhanced IGF-I signaling. J. Biol. Chem. 271: 9287-9290
26. 26 Baker J., Liu J.-P., Robertson E. J. and Efstratiadis A. (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82
27. 27 DeChiara T. M., Efstratiadis A. and Robertson E. J. (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80
28. 28 Powell-Braxton L., Hollingshead P., Warburton C., Dowd M., Pitts-Meek S., Dalton D. et al. (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev. 7: 2609-2617
29. 29 Liu J.-P., Baker J., Perkins A. S., Robertson E. J. and Estratiadis A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf 1r). Cell 75: 59-72
30. 30 Bondy C. A., Werner H., Roberts C. T. Jr and LeRoith D. (1990) Cellular pattern of insulin-like growth factor I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol. Endocrinol. 4: 1386-1398
31. 31 Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts C. T. Jr and LeRoith D. (1989) Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 86: 7451-7455
32. 32 Baserga R. and Rubin R. (1993) Cell cycle and growth control. Crit. Rev. Eukaryot. Gene Expr. 3: 47-61
33. 33 Accili D., Drago J., Lee E. J., Johnson M. D., Cool M. H., Salvatore P. et al. (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12: 106-109
34. 34 Wang Z.-Q., Fung M. R., Barlow D. P. and Wagner E. F. (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372: 464-467
35. 35 Ludwig T., Eggenschwiler J., Fisher P., D'Ercole A. J., Davenport M. L. and Efstratiadis A. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177: 517-535
36. 36 Roback E. W., Barakat A. J., Dev V. G., Mbikay M., Chreitien M. and Butler M. G. (1991) An infant with deletion of the distal long arm of chromosome 15 (q26.1-qter) and loss of insulin-like growth factor I receptor gene. Am. J. Med. Genet. 38: 74-79
37. 37 Siebter T., Lopazynski W., Terry C. L., Casella S. J., Munson P., De Leon D. et al. (1995) Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. J. Clin. Endocrinol. Metab. 80: 3447-3457
38. 38 Peoples R., Milatovich A. and Franeke U. (1995) Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 70: 228-234
39. 39 Woods K. A., Camacho-Hubner C., Savage M. O. and Clark A. J. L. (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New Engl. J. Med. 335: 1363-1367
40. 40 Werner H. and LeRoith D. (1996) The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68: 183-223
41. 41 Baserga R. (1998) The IGF-I receptor in normal and abnormal growth. In: Hormones and Growth Factors in Development and Neoplasia. pp. 269 287, Dickson R. and Salomon D. S. (eds), Wiley-Liss, New York
42. 42 Russell W. E., Van Wyk J. J. and Pledger W. J. (1984) Inhibition of the mitogenic effect of plasma by a monoclonal antibody to somatomedin C. Proc. Natl. Acad. Sci. USA 81: 2389-2393
43. 43 Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P. et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566
44. 44 Hankinson S. E., Willett W. C., Colditz G. A., Hunter D. J., Michaund D. S., Deroo B. et al. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396
45. 45 Baserga R., Sell C., Porcu P. and Rubini M. (1994) The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Proliferation 27: 63-71
46. 46 Morrione A., DeAngelis T. and Baserga R. (1995) Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor gene. J. Virol. 69: 5300-5303
47. 47 Sell C., Dumenil G., Deveaud C., Miura M., Coppola D., DeAngelis T. et al. (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14: 3604-3612
48. 48 Sell C., Rubini M., Rubin R., Liu J.-P., Efstratiadis A. and Baserga R. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90: 11217-11221
49. 49 Kaleko M., Rutter W. J. and Miller A. D. (1990) Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10: 464-473
50. 50 Harrington E. A., Bennett M. R., Fanidi A. and Evan G. I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295
51. 51 Rodriguez-Tarduchy G., Collins M. K. F., Garcia I. and Lopez-Rivas A. (1992) Insulin-like growth factor-I inhibits apoptosis in IF-3-dependent hemopoietic cells. J. Immunol. 149: 535-540
52. 52 Resnicoff M., Burgaud J.-L., Rotman H. L., Abraham D. and Baserga R, (1995) Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res. 55: 3739-3741
53. 53 Sell C., Baserga R. and Rubin R. (1995) Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55: 303-306
54. 54 Holly J. M. P., Gunnell D. J. and Davey Smith G. (1999) Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol. 162: 321-330
55. 55 Hernandez-Sanchez C., Werner H., Roberts C. T. Jr, Woo E. J., Hun D. W., Rosenthal S. M. et al. (1997) Differential regulation of IGF-I receptor gene expression by IGF-I and basic fibroblast growth factor. J. Biol. Chem. 272: 4663-4670
56. 56 Rubini M., Werner H. Gandini E., Roberts C. T. Jr, LeRoith D. and Baserga R. (1994) Platelet-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp. Cell Res. 211: 374-379
57. 57 Rosenthal S. M., Brown E. J., Brunetti A. and Goldfine I. D. (1991) Fibroblast growth factor inhibits insulin-like growth factor II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells. Mol. Endocrinol. 5: 678-684
58. 58 Werner H. and LeRoith D. (1997) The insulin-like growth factor-I receptor signaling pathways are important for tumorigencsis and inhibition of apoptosis. Crit. Rev. Oncog. 8: 71-92
59. 59 Baserga R., Hongo A., Rubini M., Prisco M. and Valentinis B. (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332: F105-F126
60. 60 Rosenfeld R. G. and Hintz R. L. (1980) Characterization of a specific receptor for somatomedin C (Sm-C) on cultured human lymphoblasts: evidence that Sm-C modulates homologous receptor concentration. Endocrinology 107: 1841-1848
61. 61 Clarke R. B., Howell A. and Anderson E. (1997) Type 1 insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br. J. Cancer 75: 251-257
62. 62 Reiss K., Ferber A., Travali S., Porcu P., Phillips P. D. and Baserga R. (1991) The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res. 51: 5997-6000
63. 63 Travali S., Reiss K., Ferber A., Petralia S., Mercer W. E., Calabreta B. et al. (1991) Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor I in 3T3 fibroblasts. Mol. Cell. Biol. 11: 731-736
64. 64 Kim S. O., Park J. G. and Lee Y. I. (1996) Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res. 56: 3831-3836
65. 65 Kozma L. M. and Weber M. J. (1990) Constitutive phosphorylation of the receptor for insulinlike growth factor I in cells transformed by the src oncogene. Mol. Cell. Biol. 10: 3626-3634
66. 66 Peterson J. E., Jelinek T., Kaleko M., Siddle K. and Weber M. J. (1994) C phosphorylation and activation of the IGF-I receptor in src-transformed cells. J. Biol. Chem. 269: 27315-27321
67. 67 Knudson A. G. (1993) Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90: 10914-10921
68. 68 Marshall C. J. (1991) Tumor suppressor genes. Cell 64: 313-326
69. 69 Weinberg R. (1993) Tumor suppressor genes. Neuron 11: 191-196
70. 70 Werner H. (1998) Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression. Mol. Cell. Endocrinol. 141: 1-5
71. 71 Rauscher F. J. III (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7: 896-903
72. 72 Werner H., Re G. G., Drummond I. A., Sukhatme V. P., Rauscher F. J. III, Sens D. A. et al. (1993) Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms' tumor gene product. Proc. Natl. Acad. Sci. USA 90: 5828-5832
73. 73 Werner H., Rauscher F. J. III, Sukhatme V. P., Drummond I. A., Roberts C. T. Jr and LeRoith D. (1994) Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J. Biol. Chem. 269: 12577-12582
74. 74 Werner H., Shen-Orr Z., Rauscher F. J. III, Morris J. F., Roberts C. T. Jr and LeRoith D. (1995) Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol. 15: 3516-3522
75. 75 Rauscher F. J. III, Benjamin L. E., Fredericks W. J. and Morris J. F. (1994) Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewings' sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor. Cold Spring Harbor Symp. Quant. Biol. 59: 137-146
76. 76 Ladanyi M. and Gerald W. (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 54: 2837-2840
77. 77 Gerald W. L., Rosai J. and Ladanyi M. (1995) Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc. Natl. Acad. Sci. USA 92: 1028-1032
78. 78 Karnieli E., Werner H., Rauscher F. J. III, Benjamin L. E. and LeRoith D. (1996) The IGF-I receptor gene promoter is a molecular tanget for the Ewings' sarcoma-Wilms' tumor 1 fusion protein. J. Biol. Chem. 271: 19304-19309
79. 79 Ohlsson C., Kley N., Werner H. and LeRoith D. (1998) p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 139: 1101-1107
80. 80 Werner H., Karnieli E., Rauscher F. J. III and LeRoith D. (1996) Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 93: 8318-8323
81. 81 Zhang L., Kashanchi F., Zhan Q., Zhan S., Brady J. N., Fornace A. J. et al. (1996) Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis. Cancer Res. 56: 1367-1373
82. 82 Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B. R. et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 1367-1373